The misregulation of Sik2 and Sik3 being detected in several cancer cases [39, 48] at both genetic and epigenetic levels [69], and Sik3 being established as an ovary cancer marker [70] are consistent with our finding that Siks can promote tumorigenesis. The gene discussed is SIK3; the disease is cancer.